Baker Bros. Advisors »

Invitae Corporation shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Invitae Corporation shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Invitae Corporation

Tip: Access up to 7 years of quarterly data

All positions including Invitae Corporation held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Invitae Corporation by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $131M 300M 0.44
2023-09-30 $130M 300M 0.43
2023-06-30 $135M 300M 0.45

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Mirati Therapeutics
Immunocore Holdings Ads (IMCR)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Invitae Corporation Notes 1.5% 4/1/2028 (Principal)
Abcellera Biologics (ABCL)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Entrada Therapeutics (TRDA)
Ultragenyx Pharmaceutical (RARE)

View all positions for Baker Bros. Advisors

Top funds holding Invitae Corporation

Baker Bros. Advisors

View all funds holding Invitae Corporation